Use of SGLT2 Inhibitors During Ramadan: An Expert Panel Statement

Fasting from dawn to sunset, during the holy month of Ramadan, constitutes one of the five main pillars in Islam and is observed by the majority of Muslims. Owing to important physiological changes, Ramadan fasting holds a crucial place in the context of diabetes management. Approximately one-fifth of the world ’s Muslim population resides in the Middle East and Africa (MEA) region. To discuss the challenges and management of diabetes during Ramadan fasting in the MEA region, a panel of 12 experts in the field of diabetes from across the MEA region attended two expert committee meetings held in Dubai.

Source: Diabetes Research and Clinical Practice - September 20, 2020 Category: Endocrinology Authors: Mohamed Hassanein, Alaaeldeen Bashier, Hoosen Randeree, Megahed Abouelmagd, Waleed AlBaker, Bachar Afandi, Omar Abu Hijleh, Inass Shaltout, Magdy EI-Sharkawy, Selcuk Dagdelen, Samir Assaad Khalil Source Type: research